Australia's most trusted
source of pharma news
Wednesday, 12 November 2025
Posted 11 November 2025 AM
Fresh from winning a Bronze Stevie with agency partner Pintar Health Connect, Echo Therapeutics has marked another milestone with the appointment of Matthew Ryan to the newly created role of Head of Business Development.
Echo, founded by former Roche high-flyer Jude D'Silva in 2023, has been thriving in a niche market creating new commercial opportunities that reignite established brands and enhance patient outcomes.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.